BIOS Health develops neural interfaces and AI technology to read and write neural data, enabling real-time analysis of the nervous system's signals. This approach addresses the malfunctioning signals that can lead to diseases, facilitating the creation of targeted pharmaceuticals and software-delivered therapies.
Funding
$25.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+7Founders
Product
Problem
Many diseases arise from malfunctioning signals within the nervous system, but current methods lack the ability to interpret and modulate these signals in real time. This limitation hinders the development of targeted therapies that can address the root cause of these conditions.
Solution
BIOS Health is developing neural interfaces and AI-driven technology to read and write neural data, enabling real-time analysis and correction of the nervous system's signals. Their platform aims to create a new field of digital health treatments by providing insights into the effects of pharmaceuticals on the nerves, leading to more precise drug creation and software-delivered treatments directly to the nervous system. The technology leverages neural biomarkers to understand diseases and respond to them, effectively reading and writing the body’s neural signals in real time. BIOS envisions a future of personalized medicine with improved healthcare experiences and better quality of life for individuals living with lifelong conditions.
Target Audience
The primary target audience includes pharmaceutical companies seeking to improve drug development, as well as healthcare providers and researchers interested in neural digital therapies.
Features
- Proprietary neural interface and AI platform for real-time measurement and analysis of neural data in both acute and chronic settings
- Neural biomarker discovery for insights into diseases and creation of new treatments
- Neural Dosing Platform combining neural recordings with AI and ML for personalized neural therapies
- Identification of neural biomarkers to profile patients more effectively and target existing drugs
- Technology capable of providing real-time insights into how pharmaceuticals affect the nervous system